CompoAtlas

Nutragenius Formula - Weight 456 Softgel

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phaseolus vulgaris

Source : Graine(s)

15 mgNot calculated
bêta-glucane

Source : Graine(s)

20 mgNot calculated
L-carnitine

Source : L-tartrate de carnitine

40 mgNot calculated
Sel de calcium-potassium d'acide (-)-hydroxycitrique

Source : Écorce du fruit

Potency : 60 % Hydroxycitric acid

260 mgNot calculated
Sel de calcium-potassium d'acide (-)-hydroxycitrique

Source : Écorce du fruit

Potency : 16 % Potassium

Not specifiedNot calculated
Sel de calcium-potassium d'acide (-)-hydroxycitrique

Source : Écorce du fruit

Potency : 11 % Calcium

Not specifiedNot calculated
Camellia sinensis

Source : Feuille

Potency : 60 % EGCG

80 mgNot calculated
Camellia sinensis

Source : Feuille

Potency : 20 % Caffeine

Not specifiedNot calculated
Gymnema sylvestre

Source : Feuille

Potency : 25 % Gymnemic acids

10 mgNot calculated
Arctium lappa

Source : Racine séchée

Extraction ratio : 10:1

Dry plant equivalent : 210 mg

21 mgNot calculated

Non-medicinal ingredients

Tocopherols Excipient NF, Lécithine, Huile de Canola, Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Softgel capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Arcticum Lappa is traditionally used in Herbal Medicine as an alterative to help remove accumulated waste products via the kidneys, skin and mucus membranes. Used as an adjunct to a weight management program in combination with healthy diet and regular exercise. Could help to temporarily increase satiety/feeling of fullness.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80047090
Status
Inactive licence
Licence date
11 December 2013
Revision date
Not provided
Form
Gélule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80047090

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-carnitine
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 25 July 2025

  • Arctium lappa
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Nutragenius Formula - Weight 456 Softgel”, https://compoatlas.com/en/supplements/canada/80047090-nutragenius-formula-weight-456-softgel, updated 11 December 2013.

Enter to analyse, Shift+Enter for a new line